Fusarium keratitis in South India: Causative agents, their antifungal susceptibilities and a rapid identification method for the fusarium solani species complex

Mycoses

Volumn 56, Issue 5, 2013, Pages 501-511

  Homa, Mónika ^a   Shobana, Coimbatore S ^b   Singh, Yendrembam R B ^b,c   Manikandan, Palanisamy ^c   Selvam, Kanesan P ^d   Kredics, László ^a   Narendran, Venkatapathy ^c   Vágvölgyi, Csaba ^a   Galgóczy, László ^a  

^a UNIVERSITY OF SZEGED   (Hungary)

^b Dr GR Damodaran College of Science   (India)

^c ARAVIND EYE HOSPITAL   (India)

^d MR Government Arts College   (India)

Author keywords

Antifungal susceptibility; Fusarium spp; Keratomycosis; Molecular identification; Phylogenetic analysis

Indexed keywords

AMPHOTERICIN B; ANTIFUNGAL AGENT; BETA TUBULIN; CLOTRIMAZOLE; ECONAZOLE; ITRACONAZOLE; NATAMYCIN; TERBINAFINE; VORICONAZOLE;

ANTIFUNGAL SUSCEPTIBILITY; ARTICLE; BROTH DILUTION; FUNGUS IDENTIFICATION; FUNGUS ISOLATION; FUSARIUM; FUSARIUM SOLANI; HUMAN; INDIA; KERATITIS; KERATOMYCOSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; RESTRICTION SITE;

ANTIFUNGAL SUSCEPTIBILITY; FUSARIUM SPP; KERATOMYCOSIS; MOLECULAR IDENTIFICATION; PHYLOGENETIC ANALYSIS;

ANTIFUNGAL AGENTS; DNA, FUNGAL; FUSARIOSIS; FUSARIUM; HUMANS; INDIA; KERATITIS; MICROBIAL SENSITIVITY TESTS; MICROBIOLOGICAL TECHNIQUES; MOLECULAR DIAGNOSTIC TECHNIQUES; PEPTIDE ELONGATION FACTOR 1; SEQUENCE ANALYSIS, DNA; TUBULIN;

FUSARIUM; FUSARIUM DIMERUM; FUSARIUM INCARNATUM; FUSARIUM NAPIFORME; FUSARIUM OXYSPORUM; FUSARIUM SOLANI;

EID: 84881030452     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12062     Document Type: Article

References (50)

1. Bharathi MJ, Ramakrishnan R, Vasu S, Meenakshi R, Palaniappan R. Epidemiological characteristics and laboratory diagnosis of fungal keratitis. A three-year study. Indian J Ophthalmol 2003; 51: 315-21.
2. Kalkanci A, Ozdek S. Ocular fungal infections. Curr Eye Res 2011; 36: 179-89.
3. Bharathi MJ, Ramakrishnan R, Meenakshi R, Padmavathy S, Shivakumar C, Srinivasan M. Microbial keratitis in South India: influence of risk factors, climate, and geographical variation. Ophthalmic Epidemiol 2007; 14: 61-9.
4. Deorukhkar S, Katiyar R, Saini S. Epidemiological features and laboratory results of bacterial and fungal keratitis: a five-year study at a rural tertiary-care hospital in western Maharashtra, India. Singapore Med J 2012; 53: 264-7.
5. Chander J, Singla N, Agnihotri N, Arya SK, Deep A. Keratomycosis in and around Chandigarh: a five-year study from a north Indian tertiary care hospital. Indian J Pathol Microbiol 2008; 51: 304-6.
6. Rautaraya B, Sharma S, Kar S, Das S, Sahu SK. Diagnosis and treatment outcome of mycotic keratitis at a tertiary eye care center in eastern India. BMC Ophthalmol 2011; 11: 39.
7. Chakrabarti A, Singh R. The emerging epidemiology of mould infections in developing countries. Curr Opin Infect Dis 2011; 24: 521-6.
8. Azor M, Gené J, Cano J, Guarro J. Universal in vitro antifungal resistance of genetic clades of the Fusarium solani species complex. Antimicrob Agents Chemother 2007; 51: 1500-3.
9. Wang H, Xiao M, Kong F et al. Accurate and practical identification of 20 Fusarium species by seven-locus sequence analysis and reverse line blot hybridization, and an in vitro antifungal susceptibility study. J Clin Microbiol 2011; 49: 1890-8.
10. Yavas GF, Oztürk F, Küsbeci T et al. Antifungal efficacy of voriconazole, itraconazole and amphotericin B in experimental Fusarium solani keratitis. Graefes Arch Clin Exp Ophthalmol 2008; 246: 275-9.
11. O'Donnell K, Sutton DA, Rinaldi MG et al. Internet-accessible DNA sequence database for identifying fusaria from human and animal isolates. J Clin Microbiol 2010; 48: 3708-18.
12. Clinical and Laboratory Standards Institute. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi. In: Approved Standard CLSI Document M38-A2. Wayne, PA: CLSI, 2008.
13. O'Donnell K, Cigelnik E. Two divergent intragenomic rDNA ITS2 types within a monophyletic lineage of the fungus Fusarium are nonorthologous. Mol Phylogenet Evol 1997; 7: 103-16.
14. O'Donnell K, Kistler HC, Cigelnik E, Ploetz RC. Multiple evolutionary origins of the fungus causing Panama disease of banana: concordant evidence from nuclear and mitochondrial gene genealogies. Proc Natl Acad Sci USA 1998; 95: 2044-9.
15. Geiser DM, Del Mar Jiménez-Gasco M, Kang S et al. FUSARIUM-ID v. 1.0: a DNA sequence database for identifying Fusarium. Eur J Plant Pathol 2004; 110: 473-9.
16. Altschul SF, Gish W, Miller W, Myers EW, Lipman DJ. Basic local alignment search tool. J Mol Biol 1990; 215: 403-10.
17. Larkin MA, Blackshields G, Brown NP et al. Clustal W and Clustal X version 2.0. Bioinformatics 2007; 23: 2947-8.
18. Hall TA. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 1999; 41: 95-8.
19. Posada D. jModelTest: phylogenetic model averaging. Mol Biol Evol 2008; 25: 1253-6.
20. Guindon S, Gascuel O. A simple fast and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 2003; 52: 696-704.
21. Soltis PS, Soltis DE. Applying the bootstrap in phylogeny reconstruction. Stat Sci 2003; 18: 256-67.
22. Huelsenbeck JP, Ronquist F. MrBayes: Bayesian inference of phylogenies. Bioinformatics 2001; 17: 754-5.
23. He D, Hao J, Zhang B et al. Pathogenic spectrum of fungal keratitis and specific identification of Fusarium solani. Invest Ophthalmol Vis Sci 2011; 52: 2804-8.
24. Eliopoulos GM, Moellering RC Antimicrobial combinations. In: Lorian V (ed), Antibiotics in Laboratory Medicine, 4th edn. Baltimore, MD: The Williams and Wilkins Co., 1996: 330-96.
25. Johnson MD, MacDougall C, Ostrosky-Zeichner L, Perfect JR, Rex JH. Combination antifungal therapy. Antimicrob Agents Chemother 2004; 48: 693-715.
26. Odds FC. Synergy, antagonism, and what the chequerboard puts between them. J Antimicrob Chemother 2003; 52: 1.
27. Naiker S, Odhav B. Mycotic keratitis: profile of Fusarium species and their mycotoxins. Mycoses 2004; 47: 50-6.
28. Azor M, Gené J, Cano J, Manikandan P, Venkatapathy N, Guarro J. Less frequent species of Fusarium of clinical interest: correlation between morphological and molecular identification and antifungal susceptibility. J Clin Microbiol 2009; 47: 1463-8.
29. Lu X, Zhu M, Shang X et al. Comparative sequence analysis of Fusarium spp. isolated from fungal keratitis specimens. Clin Microbiol Infect 2012; 18: 174.
30. Schroers H-J, O'Donnell K, Lamprecht SC et al. Taxonomy and phylogeny of the Fusarium dimerum species group. Mycologia 2009; 101: 44-70.
31. Xie L, Zhai H, Zhao J, Sun S, Shi W, Dong X. Antifungal susceptibility for common pathogens of fungal keratitis in Shandong Province. China. Am J Ophthalmol 2008; 146: 260-5.
32. Marasas WFO, Rabie CJ, Lübben A. Fusarium napiforme, a new species form millet and sorghum in Southern Africa. Mycologia 1987; 76: 910-4.
33. Magnoli CE, Saenz MA, Chiacchiera SM, Dalcero AM. Natural occurrence of Fusarium species and fumonisin-production by toxigenic strains isolated from poultry feeds in Argentina. Mycopathologia 1999; 145: 35-41.
34. Jeschke N, Nelson PE, Marasas WFO Fusarium spp. isolated from soil samples collected at different altitudes in the Transkei, southern Africa. Mycologia 1190; 82: 727-33.
35. Sangalang AE, Burgess LW, Backhouse D, Duff J, Wurst M. Mycogeography of Fusarium species in soils from tropical, arid and Mediterranean regions of Australia. Mycol Res 1995; 99: 523-8.
36. Melcher GP, McGough DA, Fothergill AW, Norris C, Rinaldi MG. Disseminated hyalohyphomycosis caused by a novel human pathogen. Fusarium napiforme. J Clin Microbiol 1993; 31: 1461-7.
37. Lee SK, Kim SS, Nahm DH et al. Hypersensitivity pneumonitis caused by Fusarium napiforme in a home environment. Allergy 2000; 55: 1190-3.
38. Unoura K, Miyazaki Y, Sumi Y, Tamaoka M, Sugita T, Inase N. Identification of fungal DNA in BALF from patients with home-related hypersensitivity pneumonitis. Respir Med 2011; 105: 1696-703.
39. Nucci M, Anassie E. Fusarium infections in immunocompromised patients. Clin Microbiol Rev 2007; 20: 695-704.
40. Lalitha P, Prajna NV, Kabra A, Mahadevan K, Srinivasan M. Risk factors for treatment outcome in fungal keratitis. Ophthalmology 2006; 113: 526-30.
41. Thomas PA. Fungal infections of the cornea. Eye 2003; 17: 852-62.
42. Alastruey-Izquierdo A, Cuenca-Estrella M, Monzón A, Mellado E, Rodríguez-Tudela JL. Antifungal susceptibility profile of clinical Fusarium spp. isolates identified by molecular methods. J Antimicrob Chemother 2008; 61: 805-9.
43. Iqbal NJ, Boey A, Park BJ, Brandt ME. Determination of in vitro susceptibility of ocular Fusarium spp. isolates from keratitis cases and comparison of Clinical and Laboratory Standards Institute M38-A2 and E test methods. Diagn Micr Infec Dis 2008; 62: 348-50.
44. Tan AL, Cha KS. In vitro activities of antifungal drugs against yeasts isolated from blood cultures and moulds isolated from various clinically significant sites in Singapore. Ann Acad Med Singapore 2008; 37: 841-6.
45. Azor M, Gené J, Cano J et al. In vitro antifungal susceptibility and molecular characterization of clinical isolates of Fusarium verticillioides (F. moniliforme) and Fusarium thapsinum. Antimicrob Agents Chemother 2008; 52: 2228-31.
46. Pujol I, Guarro J, Gené J, Sala J. In-vitro antifungal susceptibility of clinical and environmental Fusarium spp. strains. J Antimicrob Chemother 2008; 39: 163-7.
47. Liang QF, Jin XY, Wang XL, Sun XG. Effect of topical application of terbinafine on fungal keratitis. Chin Med J 2009; 122: 1884-8.
48. Dong XH, Gao WJ, He XP. Antifungal efficacy of natamycin in experimental Fusarium solani keratitis. Int J Ophthalmol 2012; 5: 143-6.
49. Pradhan L, Sharma S, Nalamada S, Sahu SK, Das S, Garg P. Natamycin in the treatment of keratomycosis: correlation of treatment outcome and in vitro susceptibility of fungal isolates. Indian J Ophthalmol 2011; 59: 512-4.
50. Li L, Wang Z, Li R, Luo S, Sun X. In vitro evaluation of combination antifungal activity against Fusarium species isolated from ocular tissues of keratomycosis patients. Am J Ophthalmol 2008; 146: 724-8.